Near-infrared Spectroscopy and Skin Tone in Children: A Prospective Cohort Study
- PMID: 40880206
- PMCID: PMC12520187
- DOI: 10.1097/ALN.0000000000005738
Near-infrared Spectroscopy and Skin Tone in Children: A Prospective Cohort Study
Abstract
Background: Retrospective studies suggest that pulse oximetry overestimates saturation in children from races that may be associated with darker skin tone. Near-infrared spectroscopy (NIRS) relies on similar optical technology, but less is known about the effect of skin tone on NIRS. This study aimed to quantify the effect of skin tone on NIRS performance.
Methods: Consecutive patients under 21 yr old undergoing cardiac catheterization were enrolled (N = 110). Skin tone was measured using spectrophotometry. Regional oxygen saturation was recorded from a Medtronic (USA) INVOS 5100C NIRS device placed on the forehead and was compared to the mixed venous saturation. Multivariable linear regressions were used to determine the effect of skin tone measured by individual typology angle (ITA).
Results: Mean bias was larger for patients with darker skin in ITA categories 5 and 6 at -12.8% compared to ITA categories 3 and 4 at -2.5% with a difference of 10.3% (95% CI, 4.4 to 16.3; P < 0.001) and ITA categories 1 and 2 at 0.3% with a difference of 13.1% (95% CI, 7.5 to 18.7; P < 0.001). ITA was associated with NIRS bias in multivariable regression analysis (coefficient, 0.173; P < 0.001).
Conclusions: Darker skin tone is associated with worse NIRS performance and lower NIRS values compared to mixed venous saturation for the INVOS 5100C system. This may lead to differences in care and contribute to inequities in outcomes. Better validation guidelines are needed to ensure equity in performance across varying skin tones.
Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc., on behalf of the American Society of Anesthesiologists.
Conflict of interest statement
An INVOS 5100C NIRS device was provided by Medtronic (Minneapolis, Minnesota) for the performance of this study. Medtronic had no role in the collection, analysis, or interpretation of the data. They further had no role in the writing of the report or the decision to submit for publication. Dr. Soslow also reports consulting for Capricor (San Diego, California) and Sarepta (Cambridge, Massachusetts) regarding Duchenne muscular dystrophy therapeutics and teaching for NS Pharma (Paramus, New Jersey). The other authors declare no competing interests.
Figures
References
-
- Massey SL, Weinerman B, Naim MY: Perioperative neuromonitoring in children with congenital heart disease. Neurocrit Care 2024; 40:116–29. doi:10.1007/s12028-023-01737-x - PubMed
-
- Agudelo-Pérez S, Troncoso G, Roa A, et al. : Cerebral rScO2 measured by near-infrared spectroscopy (NIRS) during therapeutic hypothermia in neonates with hypoxic−ischemic encephalopathy: A systematic review. J Mother Child 2024; 28:33–44. doi:10.34763/jmotherandchild.20242801.d-24-00010 - PMC - PubMed
-
- Kooi EMW, Mintzer JP, Rhee CJ, et al. : Neonatal somatic oxygenation and perfusion assessment using near-infrared spectroscopy: Part of the series on near-infrared spectroscopy by the European Society of Paediatric Research Special Interest Group “Near-Infrared Spectroscopy.” Pediatr Res 2024; 96:1180–94. doi:10.1038/s41390-024-03226-z - PubMed
-
- Zaleski KL, Kussman BD: Near-infrared spectroscopy in pediatric congenital heart disease. J Cardiothorac Vasc Anesth 2020; 34:489–500. doi:10.1053/j.jvca.2019.08.048 - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
